SCHEMBL5208612

SCHEMBL5208612

CCCc1cc(-c2ccc(F)cc2)ccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.57
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
XBP1 P17861 1/20 0.50
HIF1A Q16665 1/20 0.50
ESR1 P03372 3/20 0.48
ESR2 Q92731 3/20 0.48
HSD17B1 P14061 2/20 0.47
HMGCR P04035 1/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MCL1 Q07820 1/20 0.44
GABRA1 P14867 2/20 0.42
GABRB2 P47870 2/20 0.42
CYP1A2 P05177 1/20 0.41
GCGR P47871 1/20 0.39
BACE1 P56817 1/20 0.39
CNR1 P21554 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5127450 0.89 ALOX5 (0.68) ALOX5ESR1ESR2HSD17B1HMGCR
SCHEMBL30250904 0.89 ALOX5 (0.68) ALOX5ESR1ESR2HSD17B1HMGCR
SCHEMBL8370360 0.85 HSD17B1 (0.64) LMNAMAPTESR1ESR2HSD17B1
SCHEMBL22219376 0.85 ALOX5 (0.60) ALOX5ESR1ESR2HSD17B1MCL1
SCHEMBL2718730 0.85 ALOX5 (0.60) ALOX5ESR1ESR2HSD17B1MCL1
SCHEMBL13625815 0.85 HMGCR (0.55) ALOX5LMNAMAPTXBP1HIF1A
SCHEMBL1023623 0.84 ALOX5 (0.58) ALOX5LMNAMAPTESR1ESR2
SCHEMBL7080510 0.80 ALOX5 (0.58) ALOX5ESR1ESR2HSD17B1HMGCR
SCHEMBL2410166 0.78 PPARG (0.48) ALOX5LMNAMAPTXBP1HIF1A
SCHEMBL11023467 0.77 MMP1 (0.49) LMNAMAPTHIF1AHSD17B1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040102-B1 ARYLTHIAZOLIDINEDIONE DERIVATIVES MERCK & CO INC (US) 2007-01-24 EP disclosed
EP-1194146-B1 ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES MERCK & CO INC (US) 2006-07-19 EP disclosed
EP-1040102-A4 ARYLTHIAZOLIDINEDIONE DERIVATIVES MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1194146-A4 ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES MERCK & CO INC (US) 2002-07-31 EP disclosed
US-6399640-B1 ANTIDIABETIC AGENTS; ANTICHOLESTEROL AGENTS MERCK & CO., INC. 2002-06-04 US disclosed
EP-1194146-A1 ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES Merck & Co., Inc. (US) 2002-04-10 EP disclosed
US-6200998-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS; ANTICHOLESTEROL, ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. 2001-03-13 US disclosed
WO-2000078312-A1 ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES MERCK & CO., INC. (US) 2000-12-28 WO disclosed
EP-1040102-A1 ARYLTHIAZOLIDINEDIONE DERIVATIVES Merck & Co., Inc. (US) 2000-10-04 EP disclosed
US-6008237-A POTENT AGONISTS OF PEROXIDSOME PROLIFERATOR ACTIVATED RECEPTOR; FOR CONTROLLING OR PREVENTING OF DIABETES, HYPERGLYCEMIA, HYPERLIPIDEMIA, HYPERCHOLESTEROLEMIA, ATHEROSCLEROSIS, OBESITY, VASCULAR RESTENOSIS MERCK & CO., INC. (US) 1999-12-28 US disclosed
WO-1999032465-A1 ARYLTHIAZOLIDINEDIONE DERIVATIVES MERCK & CO., INC. (US) 1999-07-01 WO disclosed